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CELL BIOLOGY AND THE GLOMERULUS
Dysfunctions of cell biological mechanisms of visceral
epithelial cell (podocytes) in glomerular diseases
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Section of Ultrastructural Pathology and Cell Biology, Department of Clinical Pathology, University of Vienna, Vienna, Austria
Diseases are frequently caused by disorders of basic cell
biological mechanisms that govern the functions of individual
tissues and organs [1]. Detailed knowledge of the molecular
pathogenesis is a prerequisite for the design of specific thera-
pies, and recent progress in this field was encouraging. Exam-
ples are malfunctions caused by genetic defects, such as in
storage diseases in which the lysosomal segment of the en-
docytic pathways lacks the correct digestive enzymes [2].
Another cause is the corruption of specific cellular mechanisms
by parasites, such as viruses which use niches in housekeeping
mechanisms to enter the host cells, to multiply, and to leave the
infected cells again [3]. Yet another possibility is the blockade
of basic cellular mechanisms by autoantibodies and subsequent
functional and physical damage of the target system, such as
antibodies to the acetyicholine receptor in myasthenia gravis
[4], or to the myelin basic protein in allergic encephalitis and
multiple sclerosis [5].
It recently has become evident that the glomerular cells,
including the podocytes, also contribute to the initiation and
propagation of glomerular damage. Although most of the patho-
logical conditions of podocytes are mere phenomenology be-
cause the underlying cell biological mechanisms are not or only
rudimentarily known at present, I will attempt to outline a few
examples of how some basic cell biological functions of
podocytes can turn into focal points of glomerular diseases. The
examples chosen are: (i) the glycocalyx, with particular refer-
ence to the correct synthesis of negatively charged anionic
molecules; (ii) the cell adhesion to the glomerular basement
membrane; (iii) the cellular organelles and compartments which
mediate endocytosis; and (iv) the de novo synthesis of proteins
and other compounds under stress situations.
The podocyte shape-surface charge-proteinuria triangle
Retraction of the foot processes of podocytes is a basic
reaction pattern in glomerular damage. There appears to be a
close relationship between the shape of podocytes, their elec-
tronegative surface charge, and proteinuria. Very little is
known about the latter interrelation, and also the understanding
of the change in shape as a function of surface charge (or vice
versa) is modest, given the many years of scientific efforts and
the availability of several useful animal models. A key to the
understanding of these important functional relations obviously
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lies in a detailed knowledge of the cell biological mechanisms
which operate in normal podocytes in vivo, and of the mole-
cules involved. In the following chapter I will review selected
aspects of the shape-surface charge interrelation, as well as one
morphologically visible aspect of the shape-proteinuria relation
of podocytes.
Retraction of foot processes. Glomerular epithelial cells are
facing the urinary space, and cover with long, finger-like
extensions the capillary loops which constitute the kidney
glomerular tuft, and which are responsible for maintainance of
the filtration function [61. The "loss" or retraction of foot
processes is one of the main reaction patterns of podocytes,
either in response to direct intoxication, for example by puro-
mycin aminonucleoside and adriamycin, or secondary to local
complement activation and insertion into the podocyte's cell
membrane in immune complex diseases, such as in Heymann
nephritis, or other proteinuric conditions. The result of the
retraction of foot processes is flat or cuboidal podocytes which
evenly cover the entire GBM, similar to conventional epithelia,
such as in renal tubules. Since this change in shape has been
attributed to reduction of surface charge [71, it is necessary to
briefly consider the disposition and composition of the
podocyte's cell membrane.
Cell membrane domains of podocytes
Since the podocytes adhere to the glomerular basement
membrane (GBM) on the one side, and expose a major part of
their cell body into the urinary space, it is to be expected that
these two membrane domains require different biophysical and
biochemical properties. The polarization of membrane domains
is a common feature in epithelial cells and is usually mediated
by tight junctions [8]. However, in glomerular epithelial cells
this separation is mediated by unique structures, the slit dia-
phragms, which span the filtration slits between two podocyte
foot processes [9]. Slit diaphragms divide the surface mem-
branes of podocytes into two domains, one which faces the
urinary space and constitutes the majority of the podocyte's
membrane, and is referred to as the "luminal membrane," to be
distinguished from that domain which is attached to the glomer-
ular basement membrane, and which is designated as the "basal
cell membrane," or "soles" of the foot processes.
The luminal cell membrane of podocytes and the glomerular
epithelial polyanion. This domain of the podocyte cell mem-
brane constitutes -95% of the entire podocyte surface, mainly
because of its high redundancy in the foot processes [10]. It is
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endowed with a relatively thick glycocalyx (Fig. 1) which
contains glycoproteins with particularly highly anionically
charged sugar side chains [11]. A short inventory of the
molecules defined so far on this membrane domain includes
heavily sialylated and sulfated glycoproteins, such as podoca-
lyxin [121 (Figs. 1B, 2A), and a specific cell membrane-associ-
ated heparan sulfate proteoglycan [13], as well as several
hydrolytic enzymes, such as aminopeptidase A and dipeptidyl
peptidase IV [14, 15]. There is little information about the lipid
composition of this membrane domain, it appears however, that
it contains much less cholesterol than the basal cell membrane,
based on freeze fracture studies in which filipin-cholesterol
complexes were quantitatively assessed in both membrane
domains [161.
Podocalyxin. Among the glycoproteins on the surface of
podocytes, the sialoglycoprotein podocalyxin deserves atten-
tion because it appears to be involved in pathological processes.
It has long been known that loss of the correct shape of foot
processes is frequently associated with a disappearance of
negatively charged compounds, in particular of sialic acid
residues [17], which can be detected by cationic dyes by light
microscopic techniques, and were designated the "epithelial
polyanion" [18]. A large proportion of sialic acid in the
podocyte is carried by the sialoglycoprotein podocalyxin [12]
which shows an apparent molecular weight of —140 kDa in in
the rat [12], and forms a doublet of 160 and 170 kDa in humans
[19]. Recently attempts have been made to clone and sequence
podocalyxin from rabbits, and the available data indicate that
its amino acid sequence is unique [20]. It contains a minimum of
—20% carbohydrate, mostly in N-glycosidically linked side
chains, with —20 sialic acid residues per podocalyxin molecule
[12]. Recent investigations have shown that podocalyxin also
contains sulfated 0-linked polysaccharide chains [21]. It ap-
pears that podocalyxin carries >80% of the sialic acid of the
glomerulus [12], and is thus a major contributor to negative
charges on the podocyte surface.
Pathology. Human minimal change nephropathy and focal
sclerosis are glomerular diseases which are characterized by
massive proteinuria, and extensive flattening of the podocytes
[22], and it was considered that these diseases are caused by
primary dysfunctions of the podocytes [23].
In a model of human minimal change disease, that is, the
intoxication of rats with puromycin aminonucleoside, it was
found that the amount of salic acid is reduced by >75%, while
the composition of the other sugars of the N-linked side chains
remains unchanged [24]. However, quantitative studies by
immunoelectron microscopy have indicated that the density of
podocalyxin molecules on the podocyte's cell membrane is not
significantly changed, when compared to normal kidneys. This
has suggested that the loss of sialic acid in podocalyxin, rather
than down-regulation of its expression is related to the exten-
sive spreading of foot processes seen in puromycin nephrosis
[241. It also appears that the reduction of sialylation is restricted
to podocalyxin, but does not affect glomerular sialoglycolipids
(unpublished data).
In summary, the presently available data give only a static
picture of a reduced number of charged sialic acid residues in
the podocalyxin molecules of diseased podocytes, but nothing
is known about the nature of the underlying mechanisms, such
catabolism of the carbohydrate side chains and the responsible
enzymes. Also the precise function of podocalyxin in the
podocyte membranes remains unknown.
Neutralization of polyanionic surface charge by polycations.
In keeping with the concept that reduction of negatively
charged groups on podocyte membranes is associated with
flattening of the foot processes, a massive retraction was
achieved by neutralizing the "epithelial polyanion" by perfu-
sion of isolated rat kidneys with medium containing polyca-
tionic compounds, such as protamine sulfate or poly-L-lysine
[25]. This effect can be reversed by subsequent perfusion with
the polyanion heparin [261.
These important experiments have raised the question
whether or not the neutralization of the negatively charged
compounds on the surface of podocytes leads to a passive
collapse of the structure of the podocytes. This, however,
appears unlikely since neutralization of the surface charges by
protamine sulfate sets in motion a complex cellular machinery
which is highly dependent on the supply of energy and of
calcium [27], and involves complex patterns of phosphorylation
of intracellular proteins [28].
Collectively it appears that reduction of the sialic acid resi-
dues and the sulfate groups on the main carrier protein podoca-
lyxin contributes to the morphologic changes observed in
podocytes. However, conflicting data to this view are derived
from experiments in which the sialic acid residues of podocytes
were removed in isolated rat kidneys which were perfused with
neuraminidase [29]. This did not result in a profound change of
foot process morphology, but appeared to increase the perme-
ability of the capillary wall. This is another point in favor of the
view that an active cellular process of the podocytes is responsible
for their change in shape, rather than just a passive collapse of
their structure by neutralization of their surface charge.
Adhesive properties of the basal cell membrane domain of
podocytes. The interaction of the podocytes with the GBM is
mediated by the membrane domain which lies below the slit
diaphragms and has direct contact to the glomerular basement
membrane. The nature of this interaction is largely unknown. It
requires, however, not only a firm adherance of the cell
membrane to the lamina rara externa, but also must permit for
some fast dynamic changes without detachment of the
podocytes, such as those induced in vitro in a few minutes by
perfusion with protamine sulfate.
The /31-integrin of podocytes. So far the only certified adhe-
sion molecule localized by immunoelectron microscopy in this
part of the cell membrane is a /31-integrin [30] (Fig. 2B). In all
likelihood the corresponding a-chain is of the a3 type, although
the localization of this integrin chain was reported only by
immunofluorescence [31]. This has raised the question as to
which ligands it binds to in the GBM matrix, presumably via
RGD-motifs [32], and whether or not this integrin is the major
anchoring mechanism of podocytes to the GBM. At present the
adherent matrix molecule(s) are not known. It also appears
unlikely that the /31-integrin represents the sole mechanism of
podocyte attachment, first because perfusion of kidneys with 20
mM EDTA buffer does not perturb the shape of podocytes,
although the binding activity of integrins is known to depend on
calcium ions [33]. Secondly, there is no change of the shape of
as potential defects in the biosynthesis or in the intracellular foot processes when isolated rat kidneys were perfused with
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high concentrations of the competing peptide RGDS (unpub-
lished observations). This peptide is known to break the inter-
action of cell membranes with the matrix, thus leading to
rounding and detachment of the cells from the substrates in
vitro by competition with the integrin binding site on fibronectin
and other ligands which contain the RGD motif [34]. This
simple experiment appears to exclude the possibility that the
ROD-binding site of the glomerular f31-integrin is the sole factor
for stabilization of the podocyte structure, and raises the
question for other additional molecules and mechanisms of
podocyte adhesion to the GBM.
Pathology. Adhesion of podocytes to the OBM is focally
reduced in pathologic conditions, causing focal detachment and
formation of pockets between the podocytes and the GBM [35].
This could be of relevance for the development of proteinuria,
because focal detachment was found to be associated with
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Fig. 1. Demonstration of the glycocalyx of the foot processes of glomerular epithelial cells (GEC) in rat kidneys. A. This specimen was prepared
by intravenous injection of horseradish peroxidase into a rat, and fixation of kidney tissue by injection into the renal parenchyma of hypertonic
aldehyde solution, 3 minutes after injection of the tracer. The fixed tissue blocks which have trapped horseradish peroxidase in the interstitial space
and in the glomeruli while being filtered, were then reacted by the diamino benzidine reaction and incubated in osmium, so that the diamino
benzidine reaction product could diffuse into all tissue spaces which were not physically occupied by molecules, resulting in a "negative staining"
of molecules on the cell surfaces. "Negative staining" of the glycocalyx of podocytes indicates that it is composed of repetitive subunits of globular
components which are concentrated in an array parallel to the cell membranes in —200 A distance from the double membrane of the cells. The
intervening space is accessible to diamino benzidine reaction product and shows sometimes stalks connecting the cell surfaces to the globular
region of the glycocalyx. Note that there is a similar surface coat also at the endothelial cells (E) indicated by a white arrowhead, but not at the
base of the foot processes which are in contact with the glomerular basement membrane (GBM). B. Peripheral capillary wall of a rat glomerulus
which was labeled for the localization of the sialoglycoprotein podocalyxin, by a pre-embedding immunogold technique. Note that the glycocalyx
is evenly marked by gold particles (arrowheads), and that this labeling is restricted to that domain of the cell membrane which faces the urinary
space (US). The distance of the gold particles is presumably due to the location of the antibody binding sites on podocalyxin in distance to the cell
membrane, as well as to the size of the IgG molecules on the tracers. Also the luminal side of the endothelium (E) facing the capillary lumen (CAP)
contains gold particles. Abbreviations are: SD, slit diaphragms which bridge the filtration slits; cp, clathrin coated pit. (X 45,000).
Fig. 2. Labeling of the membrane domains of
glomerular epithelial cells (GEC) in human
glomeruli, using antibodies to podocalyxin (A)
and to 1-integrin (B). Normal human kidney
tissue was embedded in Lowicryl K4M resin,
and labeled with a post-embedding indirect
immunogold method. A. Podocalyxin is
restricted exclusively to the luminal side of
the glomerular epithelial cells (GEC) which
face the urinary space (US). There is no
labeling of the cell membrane at the base of
the footprocesses. Arrowheads indicate gold
particles on endothelial cells. B. By contrast,
I3 integrin is exclusively found on the basal
aspect of the foot processes of glomerular
epithelial cells (arrowheads), and is absent
from the luminal domain of the glomerular
epithelial cells. (x 17,500).
increased glomerular permeability in experimental diseases,
such as puromycin nephrosis and Heymann nephritis in rats
[35] (Fig. 3). It is thought that these areas of podocyte detach-
ment locally reduce the hydraulic conductance of the glomeru-
lar filter because endogenous proteins, such as albumin and
IgG, which in normal animals do not cross the GBM, were
shown to leak at the site of focal detachment by immunocyto-
chemistry [361. Although these data were reported several years
ago, no substantial progress has been made since, although
podocytes could provide a clue as to how the glomerular
capillary wall becomes focally permeable in proteinuria.
Adhesion molecules on glomerular endothelial and inflamma-
tory cells have become a focus of intense research because they
appear to offer points of intervention for treatment of inflam-
matory lesions in glomeruli. One recent example is the appli-
cation of antibodies to ICAM- 1 which efficiently prevent the
formation of crescentic glomerular lesions in anti-GBM disease
in rats [37]. A direct participation of adhesion molecules of
podocytes in inflammatory lesions has not been shown as yet.
Slit diaphragms. In normal mature glomeruli the slit dia-
phragms show a regular porous structure [9] which resembles
desmosomes; however, recent investigations have suggested
that they may actually be related to tight junctions. This is
primarily based on the fact that the submembranous tight
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Fig. 3. Focal detachment of glomerular epithelial cells (GEC) from the basement membranes in active Heymann nephritis, 10 weeks after
immunization of rats with the kidney cortex preparation FxIA. A. Immune deposits (arrowheads) are located in the lamina rara extema, and there
is focal detachment of the glomerular epithelial cell (GEC) close to the immune deposit, as well as outside the deposit, forming huge vesicular
structures (V) within the GEC cell body. B. The matrix of an immune deposit (ID) is connected to the cell membrane at the base of a glomerular
epithelial cells by small fibrils (small arrowheads). Native ferritin which was injected intravenously 30 minutes before fixation is seen in the lamina
ram interna, and does not penetrate the glomerular basement membrane at the sites of detachment and formation of vacuoles. (A: x 10,000; B:
x 25,000).
junction protein, ZO- 1, is associated with the anchoring site of
the slit diaphragms in the cell membranes of the podocytes [38].
It has been speculated that dynamic assembly and disassembly
of junctions could be involved in regulation of the hydraulic
conductance across the glomerular capillary walls [39].
Pathology. When the foot processes of the podocytes are
retracted and flattened, such as in puromycin nephrosis in rats
and in protamine sulfate perfused rat kidneys, there is extensive
dislocation and rearrangement of slit diaphragms (Fig. 4). This
is mediated by an active process which involves phosphoryla-
tion of ZO-1 [28] and presumably other proteins also. Typical
tight junctions are frequently found in lieu of the slit diaphragms
in flattened podocytes, as indicated by focal fusions or "kisses"
of the outer leaflets of the cell membranes in sections [8, 40], or
"beaded ribbons" of intramembranous 100 A particles in
freeze fracture preparations [27, 40] (Fig, 5). Interestingly,
these junctions are assembled within a few minutes after
perfusion of rat kidneys with the cationic compounds protamine
sulfate or poly-L-lysine [26, 27, 39], suggesting that the subunits
of tight junctions are present in proximity to the slit dia-
phragms.
Recently, a monoclonal antibody was described which ap-
pears to be directed against a —51 kDal protein of rat slit
diaphragms, and which induces heavy, reversible proteinuria
upon injection [41]. This interesting antigen is not further
characterized at present, although local immune complex for-
mation clearly highlights its functional relevance, as well as that
of the slit diaphragms, for the control of glomerular permeabil-
ity.
The data summarized are yet other examples of how merely
descriptive our knowledge of basic glomerular lesions is at
present. It is not clear whether the dislocations of the slit
diaphragms are a consequence or a cause of the flattening of
podocytes. Obviously, a detailed analysis of their molecular
composition, their association with the podocyte membranes,
and their relation to tight junction components will help to
understand this functionally important aspect.
The endocytic pathway of glomerular epithellal cells
Glomerular epithelial cells are endowed with essentially the
same intracellular organelles as all other cells [42] which include
endocytic devices, such as clathrin-coated pits and noncoated
pits of the cell membranes, preferentially at their "soles" which
face the GBM, endosomal vesicles, lysosomes, and multivesic-
ular bodies. Because of their anatomical position it should be
expected that glomerular epithelial cells are in need of efficient
mechanisms to remove or reutilize materials which bind to their
membrane at the basal and presumably also luminal aspects.
However, little is known about specific receptors, the or-
ganelles, and their localization and interaction in podocytes.
Identification of some endocytic organelles was achieved in
various cells by the exposure to cationic tracers, such as
cationized ferritin. These derivatized tracer molecules appar-
ently utilize the same pathway as receptor-ligand complexes, in
that they are taken up by clathrin coated pits, are transported to
endosomes and to the trans-Golgi network, and from there to
lysosomes, or back to the cell surfaces [44]. When cationic
femtin was injected into rats it preferentially bound to the
GBM, and only few tracer particles were endocytozed [43]. A
similar picture was achieved when rat kidneys were perfused
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Fig. 4. Gallery of examples of extensive dislocation of slit diaphragms in rat kidneys induced by perfusion with protamine sulfate for 15 minutes.
A. In this example there is the formation of a tight junction (large arrowheads), distant from the original localization of the slit diaphragms close
to the GBM. Above the tight junction there is a ladder-like aggregation of slit diaphragms (small arrowheads). B. Tangential section of a similar
preparation in which the staggering of slit diaphragms is seen more clearly. Arrowheads indicate a middle line in the center of the slit diaphragms
which does not pick up electron microscopic staining. Abbreviations are: MVB, multivesicular body; US, urinary space. (x 35,000).
Fig. 5. Formation of junctions and
dislocation of slit diaphragms induced by
perfusion of isolated rat kidneys with the
polycation protamine sulfate. A. The filtration
slits are narrowed in many areas and are
occluded by tight junctions (big arrowheads),
while the slit diaphragms are dislocated and
appear to move towards the urinary space
(small arrowheads). K and C. Tight junctions
are indicated by focal contacts of the outer
leaflets of the cell membranes, and are
particularly well observed when the tissue has
been post-fixed in tannic acid-containing
solutions. D. Freeze fracture
electronmicrograph of a junctional region of
glomerular epithelial cells after protamine
sulfate perfusion. Note that there is assembly
of globular intramembranous particles to form
strands that resemble tight junctions (big
arrowheads), as well as tight packaging of
globular units with resemblance to gap
junctions. Abbreviation GBM is glomerular
basement membrane. (A: x 15,000; 13 and C:
45,000; D: 65,000).
first with protamine sulfate, and followed by heparin, producing of podocytes was achieved when rat kidneys were perfused ex
large globular complexes in the lamina rara externa, which were vivo with cationized horseradish peroxidase (p1 —8.5), and the
then endocytosed by podocytes [45]. kidneys were reconnected to the circulation (Figs. 6, 7). Under
A more complete labeling of the entire endocytic machinery these conditions the tracer penetrates the glomerular filter and
.i•.,t._.g btA;;r
4
Fig. 6. Display of the organdies of the endocytic pathway of glomerular epithelial cells by the uptake of cationic horseradish peroxidase. The
cationized enzyme (p1 —8.5) was perfused through isolated rat kidneys ex vivo, the unbound excess enzyme was flushed, and the renal vasculature
was reconnected to the circulation. Kidneys were fixed one hour after reconnection, and cationized horseradish peroxidase was localized by the
diaminobenzidine reaction. A. Micrograph showing the uniform labeling of the GEM, the surface of the glomerular epithelial cells, and the
endotheial luminal cell surface. Clathnn coated pits (cp), as well as several small vesicles within the cytoplasm of the podocytes contain reaction
product. There are several small vesicles close to the Golgi apparatus, some of which are multivesicular bodies. B. A multivesicular body contains
abundant reaction product. C. Clathrin-coated pits (cp) remove the cationic tracer enzyme from the base of the foot processes, and also from the
surface of podocytes. The intracellular transport of the tracer is mediated by coated vesicles (cv). D. Capillary wall showing the uptake of
cationized peroxidase from the GBM via coated pits (cp) and coated vesicles (cv). There is also an uptake in vesicles in endothelial cells (v).
Abbreviations are: Cap, capillary lumen; er, endoplasmic reticulum. (A: X 10,000; B: x 9,000; C and D: 25,000).
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Fig. 7. Similar preparation as in Fig. 6, fixed 8 hours after labeling with calionic horseradish peroxidase and reconnection to the circulation. A.
The tracer is present in a more granular pattern in the glomerular basement membrane, sometimes lying below the slit diaphragms. Within the
podocytes numerous multivesicular bodies (mvb) are observed. Note that the cell surface of the podocytes is almost completely cleared of the
cationized tracer. B. A large multi-vesicular body is engorged with the tracer enzyme. There is also a coated vesicle carrying the tracer (cv). The
arrowhead indicates an invagination of the membrane of the multivesicular body, presumably caused by a vesicle caught in the process of
delivering its contents into the lumen. Multivesicular bodies of this size frequently exocytose their contents into the urinary space. Abbreviations
are: E, endothelial cell; mvb, multivesicular body. (A: X 14,000; B: X 26,000).
sticks evenly to the entire GBM and to the basal membrane
domain of podocytes (Fig. 6), Within a few minutes after
re-establishing the circulation, the cationized horseradish per-
oxidase in the glomerular basement membrane appears to
become detached and is picked up by numerous clathrin-coated
pits, which retrieve into the cell and deliver their contents
preferentially to multivesicular bodies which apparently are an
endocytic/lysosomal compartment of podocytes [46]. In these
organelles the cationized horseradish peroxidase accumulates
for several days after application (Fig. 7), and eventually is
discharged by exocytosis of the multivesicular bodies into the
urinary space. This indicates that the endocytic pathway in
podocytes appears to involve coated pits and vesicles and
multivesicular bodies. The fate of molecules which have en-
tered the multivesicular bodies is not certain; it could be that
they are digested and reutilized by the cell, or that multivesic-
ular bodies empty their content into the urinary space. This may
be a special mechanism of podocytes for releasing digested
material, especially when the endocytic pathway is activated,
for example by the feeding of cationic horseradish peroxidase,
or induction of immune deposits. Typical lysosomes with
homogenous content, as are found in proximal tubules, are
usually rare in normal kidneys but they may become numerous
and large in pathological conditions, such as in nephrosis
induced by puromycin aminonucleoside [40].
Apparently there is some basic endocytosis of various mole-
cules going on all the time, presumably as a normal housekeep-
ing mechanism of podocytes. For example, the LDL-receptor
related gp330 glycoprotein appears not only in the coated pits
on the sole of the foot processes, but occasionally also in
multivesicular bodies in normal animals [47].
Heymann nephritis
It was unexpected that single segments of the endocytic
machinery of podocytes are involved in the pathogenesis of rat
Heymann nephritis, a faithful experimental rat model disease of
human membranous nephropathy [48, 49]. This disease in-
volves: (i) the in situ formation of immune complexes [50] with
the gp330 Heymann nephritis complex (HNAC) antigens that
are presented in the clathrin-coated pits on the base of the foot
processes which are the "mouth" of the endocytic system. (ii)
Secondly, the basic endocytic intracellular pathway appears to
be amplified for the removal of the complement membrane
attack complex which is formed within immune deposits [51].
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Fig. 8. Immune deposits in active Heymann nephritis (12 weeks after immunization of rats with FxJA antigen) form within the coated pits at the
base of the foot processes of glomerular epithelial cell (GEC). A. Large clathrin-coated pits (cp) with a bristle coat representing clathrin on the
cytoplasmic side of the cell membrane covers immune deposits (ID). B. Another example in which the clathrin coat can be seen very clearly (cp).
C, D and E. The immune deposits are composed of endogenous rat IgG and the gp330-Heymann nephritic complex (gp330/HNAC) which is
localized in these figures by an indirect immunoperoxidase procedure, using a monoclonal antibody against gp330. There is labeling of the matrix
of immune deposits (ID), all of which are associated with sometimes quite extensive clathrin-coated pits (cp). Gp330 is also detected within the
coated pits (cp) on the luminal cell membrane domain of podocytes. C, D and E: Examples of immune deposits in active Heymann nephritis, some
of which are large and encroach the area of the slit diaphragms (arrowheads), although remaining in contact with a coated pit (cp) which presumably
is the site where new antigen is provided for the formation of immune complexes. Immune deposits cannot be removed by endocytosis, presumably
because they are firmly attached to the glomerular basement membrane. (x 25,000).
Formation of immune deposits in clathrin-coated pits
Several aspects of the formation of immune deposits were
recently reviewed [49, 52]. In the present context only the more
recent data which can now be related to basic cell biological
housekeeping mechanisms of podocytes will be mentioned.
Clathrin-coated pits are highly specialized regions of cell
membranes, which contain a high density of receptor molecules
for various ligands, such as the LDL receptor [53]. The recep-
tor-ligand complexes are concentrated and become endocy-
tosed via clathrin-coated pits of the cell membranes, and
according to their content and other factors, may enter different
routes of vesicular traffic within the cell cytoplasm. Coated pits
are also present on the base of the foot processes, and they
obviously serve a similar purpose as in any other cells, that is,
the endocytic uptake of ligands. Since the receptors in these
coated pits have not been defined yet, the endocytosed ligands
are equally obscure at present. One apparent exception is a
membrane protein, designated gp330 [54], which is now be-
lieved to have a molecular weight of <400,000 kDa [55]. This
protein was originally identified as a nephritogenic antigen of
Heymann nephritis, and it was shown that it is exclusively
present in the clathrin-coated pits of podocytes [47]. Appar-
ently, gp330 is indeed a receptor which shows sequence homol-
ogy with the LDL receptor and which binds to several ligands,
such as lactoferrin, the plasminogen activator-inhibitor com-
plex, as well as calcium [56, 57]. However, these interactions
have only been detected in vitro mostly by ligand blotting, and
therefore may not be relevant to that occurring in vivo.
It is now established that gp330 on the soles of podocytes is
at least partially associated with a smaller -44 kDa protein [58,
59] (which was originally called C14, and thought to be a part of
gp330 molecule rather than a separate peptide) [60], and which
contains at least one nephritogenic epitope [61]. The complex of
gp330 and the 44 kDal molecule is designated the "Heymann
nephritis antigenic complex" (HNAC) [59]. Circulating anti-
bodies against nephritogenic epitopes on any of these two
molecules cross the glomerular basement membrane and bind at
the level of the coated pit, to form an initial immune complex
[49].
While ligand-receptor complexes are generally removed by
endocytosis, the situation is different in podocytes when spe-
cific divalent IgGs bind to the HNAC, in that the immune
complexes formed cannot be removed from the GBM by
endocytosis anymore. It appears that the immune complexes
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Fig. 9. Localization of the C5b-9 complement
membrane attack complex within the immune
deposits in passive Heymann nephritis, 7 days
after injection of anti-FxJA IgG. A. Extensive
clathrin coat in the membrane area of a
glomerular epithelial cell (GC) which is
associated with an immune deposit (ID). B, C,
O and E. Localization of C5b-9 neo-antigen
within the immune deposits and in close
association with cell membrane (arrow heads)
of glomerular epithelial cells, by an indirect
immunogold procedure on ultrathin frozen
sections. F. En face view of cell membrane of
a glomerular epithelial cell from a similar
preparation as used in figures B through E, as
seen by freeze fracture electron microscopy.
The arrowheads indicate clusters of large
intramembrane particles which match in size
membrane inserted C5b-9 membrane attack
complexes, indicating that membrane insertion
of C5b-9 has occurred. Abbreviation is MV,
microvilli. (A: x 35,000; B-D: x 25,000; E
and F: 65,000).
stick rapidly to some as yet undefined component of the
glomerular basement membrane which prevents them from
being removed by the podocyte [62]. The growth of these initial
immune complexes to readily visible immune deposits is appar-
ently mediated by the addition of newly synthesized gp330-
HNAC antigen at the level of coated pits which remain in
contact with the growing immune deposit, even when this has
become large (Fig. 8).
Thus, the formation of immune deposits could be viewed as a
dysfunction of the endocytic uptake of podocytes of a receptor-
immune complex formed within the clathrin coated pits at the
cell surface. The reason for this inability appears to be a so far
undefined mechanism by which the gp330-HNAC gets shed
from the cell membrane [63] and immobilized to the GBM, or
vice versa. It could be of practical relevance to understand and
manipulate the underlying molecular mechanisms, because they
could offer clues for the destabilization of immune deposits.
Endocytic organelles remove complement components in
Heymann nephritis
The amplification of the intracellular branch of the endocytic
pathway of podocytes appears to play a major role in the
handling of the C5b-9 membrane attack complex which is
generated within the immune deposits in Heymann nephritis. It
was found that C5b-9 complexes can be detected within the
immune deposits in passive Heymann nephritis and is a prereq-
uisite of glomerular damage and proteinuria [64]. While most of
the C5b-9 complexes appear to be associated with S protein/
vitronectin, to give presumably non-cytotoxic, water soluble
aggregates that are no longer able to insert into cell membranes
[65], a fraction of the C5b-9 complexes appears to escape from
this neutralizing scavenger mechanism, and is nevertheless
inserted into the podocyte's basal cell membranes where it is
detected by freeze-fracture electron microscopy, and in ultra-
thin frozen sections by indirect immunogold labeling [51] (Fig.
9). The process of membrane insertion is followed by massive
uptake of CSb-9 into podocytes by clathrin coated pits, as
detected by immunocytochemistry with antibodies to a neo-
antigenic epitope on C9 which is only available after formation
of the entire membrane attack complex [66]. Transport vesicles
then carry the C5b-9 complex into multivesicular bodies which
become numerous and large, and are engorged with membrane
fragments and CSb-9 antigenic sites. This step is followed by
exocytosis of the vesicle's content into the urinary space, thus
releasing CSb-9 antigenic fragments into the urine [51] which
can be detected there in active phases of Heymann nephritis,
and also in human membranous nephropathy [67].
Thus, the amplification of the normally ongoing endocytic
mechanisms of podocytes apparently helps to clear membrane
inserted CSb-9, and could be critical for the development of
glomerular injury, because when the capacity of this transcel-
lular transport is exceeded CSb-9 may insert into podocyte cell
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membranes and activate the cells to produce several potentially from undesirable immune complexes and complement compo-
noxious compounds. It is remarkable that this type of endocy- nents.
tosis of C5b-9 complexes appears to be restricted only to
Heymann nephritis, for reasons which are currently unknown.
When C5b-9 is generated, for example by implanted cationic
immune complexes, no membrane insertion of C5b-9 was
found, and no transcytotic mechanisms could be detected [51]
(Fig. 10).
Thus, it is possible that the gp330-HNAC, in cooperation
with CSb-9, is able to specifically activate the transcellular
transport system. It would be of some interest to identify the
molecular regulatory mechanisms because their stimulation
could assist in clearing the glomerular basement membrane
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Fig. 10. Utilization of the intracellular endocytic pathway for removal of C5b-9 membrane attack complex in passive Heymann nephritis, 7 days
after intravenous injection of anti-FxIA IgG. A. CSb-9 is located in immune deposits (ID), some of which are connected to coated pits, and it is
also found within the cell of the GEC in a multivesicular body (mvb), as shown by indirect immunoperoxidase. B. A large multivesicular body is
engorged with reaction product indicating the uptake of C5b-9. C. Dispatching of the content of a multivesicular body (arrowheads) into the urinary
space (US) by a glomerular epithelial cell. Abbreviations are: ID, immune deposits; v, vesicle which contains C5b-9. (X 12,000).
Fig. 11. Localization of H202 within the glomerular capillary wall of a proteinuric rat with passive Heymann nephritis (induced by intravenous
injection of anti-FxIA IgG 7 days before sacrifice). Isolated kidneys were perfused with a medium containing cerium ions, /3-NADPH and glucose.
A. The formation of precipitates of the locally formed H202 and the cerium ions was only seen in proteinuric rats, and it was found in a diffuse
distribution within the glomerular basement membrane (GBM), including the immune deposits (ID). This shows how a product of glomerular
epithelial cells could induce diffuse damage to the glomerular basement membrane, presumably by induction of lipid peroxidation and formation
of adducts on matrix molecules. A mitochondrium (M) of the epithelial cell is devoid of the reaction product. B. Within glomerular epithelial cells
also lysosomes (ly) contain H202-cerium precipitates. (x 12,000).
Products of podocytes under stress situations
As many other cells, podocytes produce proteins and pre-
sumably also other compounds when exposed to C5b-9 mem-
brane attack complex of complement, to subepithelial immune
deposits, and other conditions which could exert some sort of
stress. The de novo synthesized or amplified proteins appar-
ently do not include conventional heat shock proteins, such as
hsp 70 (unpublished data), but several other proteins which are
obviously determined to assist in clearing of the stimulating
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activity, such as an af33 integrin (vitronectin receptor), a CR!
receptor for C3b (unpublished observation), as well as en-
zymes, such as the NADPH oxido-reductase complex which is
used by activated neutrophilic granulocytes to generate reactive
oxygen species (ROS). The latter enzyme system is presented
as an example of how these glomerular defense mechanisms
may turn into a potential source of damage for the integrity of
the capillary filter.
ROS-generating enzymes and proteinuria in passive
Heymann nephritis
When proteinuria inducing antibodies to kidney brush border
fractions are injected intravenously into rats, immune deposits
form within a few hours, and C5b-9 activation takes place.
Typically, six to seven days after the intravenous injection of
the nephritogenic antibodies heavy proteinuria commences. It
is established that proteinuria is dependent to a large extent on
the production of free oxygen radicals in passive Heymann
nephritis, because interventional studies with oxygen radical
scavengers have shown that proteinuria can be suppressed by
>80% [68]. This has raised the question as to where the ROS
are produced, especially because proteinuria in passive Hey-
mann nephritis develops in the absence of inflammatory cells,
such as neutrophiic granulocytes. It was found that indigenous
glomerular cells, and in particular the glomerular epithelial
cells, are able to produce enzymes of the NADPH oxido-
reductase complex which is utilized by neutrophilic granulo-
cytes to generate ROS. The amount of the key enzyme,
cytochrome b558, was shown to be up-regulated, in concert with
the development of proteinuria [69]. The increase in biosynthe-
sis amounted to >25 times over normals, determined on a
mRNA basis (unpublished observation), and the amount of
enzyme produced is large enough to be detected by immuno-
cytochemical procedures [70]. Thus, immunoelectron micros-
copy has revealed that glomerular epithelial cells are a major
source of this enzyme which was found to be secreted onto the
cell surface, specifically to the basal surface which faces the
glomerular basement membrane. This situation resembles neu-
trophilic granulocytes in the respiratory burst reaction after
activation in vitro, in which the enzymes of the oxido-reductase
complex are relocated from the cell membranes of granules to
the cell surface by exocytosis and serve there as local genera-
tors of ROS on the cell surface [71, 72]. In passive Heymann
nephritis with established proteinuria oxygen radicals were
localized by a cytochemical technique throughout the glomer-
ular basement membrane (Fig. 11), thereby exposing the matrix
molecules of the GBM to these highly reactive compounds. It is
of interest that the increase of biosynthesis of cytochrome b558
was completely suppressed when immune deposits are induced
in rats which are deprived of complement, thus indicating that
the C5b-9 membrane attack complex is a trigger to the increase
in biosynthesis of the ROS-generating enzymes in passive
Heymann nephritis [70].
Collectively these data suggest that glomerular epithelial cells
could reach a state of activation by the action of complement,
and presumably also by other so far unknown molecules and
mediators, which initiate a program of de novo or increased
biosynthesis of molecules that could be useful to fight off
noxious agents, but also could lead to damage of the capillary
filter. Data derived from in vitro experiments indicate that
several compounds, including cytokines, prostaglandins and
other mediators may be produced and released into the medium
by challenged cultured glomerular epithelial cells [73]. How-
ever, it is difficult to transfer these results to the glomerulus in
situ, because the phenotypic identity of glomerular epithelial
cells in cell culture and in tissue is not fully established [74], and
the cross talk of different glomerular cells may be important and
cannot be fully mimicked in vitro. It would obviously be of
interest to determine whether or not podocytes could become
"activated" [75] in response to various attacks on their integ-
rity, by switching on a preset "emergency program" of biosyn-
thesis which includes the expression of the respiratory burst
enzymes [70], of a vitronectin-receptor related integrin (unpub-
lished data), and other, as yet unidentified compounds in vivo.
Outlook
This review summarizes several examples of fragments of
pathogenetic mechanisms of glomerular diseases which can be
attributed at present to dysfunctions of basic cell biologic
mechanisms of podocytes. It is obvious how little is known in
this field, particularly with regard to the contributions of
glomerular epithelial cells to diseases. Obviously much more
basic research is needed to understand the fundamental rela-
tions between diseases and normal cellular processes, because
they hold the keys for early detection, prevention and curing of
glomerular diseases that cripple renal function and cause human
suffering and major expenses for financially stressed health
systems.
Reprint requests to D. Kerjaschki, M.D., Department of Clinical
Pathology, Universily of Vienna, AKH, Wahringer Gürtel 18-20,
A-1090 Vienna, Austria.
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